1 National Institute for Health Research Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, UK. 2 Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 3 Neuropharmacology and Neurobiology, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. 4 NHS Blood and Transplant, Bristol, UK. 5 Address correspondence to: Richard Parker, M.B.Ch.B., M.R.C.P., National Institute for Health Research Biomedical Research Unit and Centre for Liver Research, University of Birmingham, 5th Floor IBR, Birmingham, UK B15 2TT.
Transplantation. 2013 Dec 27;96(12):1015-24. doi: 10.1097/TP.0b013e31829f7579.
This review focuses on alcohol and substance abuse in the context of solid-organ transplantation. Alcohol and substance abuse are common and may lead to a need for solid-organ transplantation and may also contribute to significant physical and psychologic problems that impact upon the recipient. Damaging levels of alcohol intake can occur in the absence of dependence. Alcohol or substance abuse after transplantation is associated with poor medication compliance and this may increase risk of graft loss. Intravenous drug use is associated with increased risk of infections (especially secondary to opportunistic organisms-bacterial, viral, protozoal, and others-and such infections may be more severe in the immunosuppressed), but there is only anecdotal evidence that such behavior has a worse outcome in transplant recipients. Whereas previous alcohol excess and drug use in kidney recipients are both associated with a small but statistically significantly increased risk of adverse outcomes (hazard ratio, 1.16-1.56), alcohol use within recommended guidelines after transplantation appears safe and possibly beneficial. Robust data are lacking for other organs, but those available suggest that heart transplantation is safe in individuals with a history of alcohol or substance abuse. Health specialists in drug or alcohol addiction should carefully screen all potential transplant candidates for these conditions, and where there is evidence of dependency or abuse, effective psychologic and physical treatment should be offered. Studies have shown that interventions such as psychologic intervention have improved alcohol behavior in the context of liver transplantation. Although there are no comparable studies with other solid-organ recipients, it is reasonable to expect transferable outcomes.
这篇综述聚焦于实体器官移植背景下的酒精和物质滥用问题。酒精和物质滥用较为常见,可能导致需要进行实体器官移植,并且还可能导致严重的身体和心理问题,影响受者。在没有依赖的情况下,也可能出现有害的酒精摄入量。移植后饮酒或滥用物质与药物依从性差有关,这可能增加移植物丢失的风险。静脉吸毒与感染风险增加相关(特别是继发于机会性生物体-细菌、病毒、原生动物等),而且这种感染在免疫抑制患者中可能更为严重,但只有一些传闻证据表明,这种行为在移植受者中的后果更差。虽然先前的过量饮酒和肾移植受者的药物使用都与不良结果的风险小幅度但具有统计学意义的增加相关(风险比为 1.16-1.56),但在移植后遵循建议的指南饮酒似乎是安全的,并且可能有益。缺乏其他器官的可靠数据,但现有的数据表明,有酒精或物质滥用史的个体进行心脏移植是安全的。药物或酒精成瘾方面的健康专家应仔细筛选所有潜在的移植候选者是否存在这些情况,对于存在依赖或滥用的证据,应提供有效的心理和身体治疗。研究表明,在肝移植背景下,心理干预等干预措施改善了酒精行为。尽管其他实体器官受者没有可比的研究,但可以预期会有可转移的结果。